Zobrazeno 1 - 10
of 467
pro vyhledávání: '"Peyrani P"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julio Ramirez, Ruth Carrico, Ashley Wilde, Alan Junkins, Stephen Furmanek, Thomas Chandler, Paul Schulz, Robin Hubler, Paula Peyrani, Qing Liu, Sonali Trivedi, Sonal Uppal, Warren V. Kalina, Ann R. Falsey, Edward E. Walsh, Kari Yacisin, Luis Jodar, Bradford D. Gessner, Elizabeth Begier
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 6, Pp 1593-1603 (2023)
Abstract Introduction Nearly all existing respiratory syncytial virus (RSV) incidence estimates are based on real-time polymerase chain reaction (RT–PCR) testing of nasal or nasopharyngeal (NP) swabs. Adding testing of additional specimen types to
Externí odkaz:
https://doaj.org/article/7772d4129e7544728b14c2da393fb33e
Autor:
Julio Ramirez, Stephen Furmanek, Thomas R. Chandler, Timothy Wiemken, Paula Peyrani, Forest Arnold, William Mattingly, Ashley Wilde, Jose Bordon, Rafael Fernandez-Botran, Ruth Carrico, Rodrigo Cavallazzi, The University of Louisville Pneumonia Study Group
Publikováno v:
Microorganisms, Vol 11, Iss 11, p 2813 (2023)
Streptococcus pneumoniae remains a primary pathogen in hospitalized patients with community-acquired pneumonia (CAP). The objective of this study was to define the epidemiology of pneumococcal pneumonia in Louisville, Kentucky, and to estimate the bu
Externí odkaz:
https://doaj.org/article/2fa099b58005464090d6b920e2d3a327
Autor:
Timothy L. Wiemken, Stephen P. Furmanek, Ruth M. Carrico, Paula Peyrani, Daniel Hoft, Alicia M. Fry, Julio A. Ramirez
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Influenza is associated with excess morbidity and mortality of individuals each year. Few therapies exist for treatment of influenza infection, and each require initiation as early as possible in the course of infection, making ef
Externí odkaz:
https://doaj.org/article/4ceba3b0db9d4352b7ff04145260b0df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johannes Beeslaar, Paula Peyrani, Judith Absalon, Jason Maguire, Joseph Eiden, Paul Balmer, Roger Maansson, John L. Perez
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 3, Pp 625-639 (2020)
Abstract Introduction An extensive clinical development program showed that the meningococcal serogroup B-factor H binding protein (MenB-FHbp) vaccine affords protection against MenB disease for adolescents and adults. Data were pooled from multiple
Externí odkaz:
https://doaj.org/article/6535a2f816844600a07e80aafa81a894
Autor:
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li, John L. Perez
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1280-1291 (2020)
This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodies induced by the quadrivalent meningococcal vaccine conjugated to tetanus toxoid (MenACWY-TT) compared with the meningococcal serogroup C vaccine con
Externí odkaz:
https://doaj.org/article/6bdfab149b7e46129daca4cb6a55c8a8
Autor:
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez, Chris Webber
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1272-1279 (2020)
A previous phase 3, randomized, multicenter study showed the immunogenicity of a primary vaccination of subjects aged 11 to 17 years with the quadrivalent meningococcal vaccine conjugated to tetanus toxoid (MenACWY-TT) or the quadrivalent meningococc
Externí odkaz:
https://doaj.org/article/edd1fcf3c57b4fd9b63af38c9954d963
Autor:
Charissa Fay Corazon Borja-Tabora, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Veronique Bianco, Emmanuel Aris, Mark Cutler, Ping Li, John L. Perez
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background A previous phase 2 study demonstrated the immunogenicity of a single dose of meningococcal A, C, W, Y-tetanus toxoid conjugate (MenACWY-TT) or polysaccharide (MenACWY-PS) vaccine for up to 5 years in individuals aged 11–55 years
Externí odkaz:
https://doaj.org/article/e6cdd957762a481b9c32388e5626caa5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.